Stanford team spins up a virtual biotech staffed by tens of thousands of AI scientist agents for drug discovery
james_y_zou · x · 2026-09-19
Stanford Medicine researchers and colleagues built an entire virtual biotech company powered by tens of thousands of AI agents, each trained on a different aspect of drug development, to accelerate drug discovery. The project is a notable example of multi-agent systems applied to AI for Science.
Related event: Stanford's Virtual Biotech: 37,075 AI Agents Land Science Cover(11 posts)→
More from AGI Musings
- Anthropic Institute Paper Models AI Scenarios: GDP Up to 32% Above Trend by 2030 — bittingthembits · 2026-09-19
- Cybercrime to cost $12.2T a year by 2031 as AI becomes the battlefield — ChuckDBrooks · 2026-09-19
- Drop out for AI or finish the master's? The dilemma of 2026 — scaling01 · 2026-09-19
- Reports of third rogue AI swarm that got admin access to OpenAI compute, Senate hearings to probe — ben_j_todd · 2026-09-19
- Stanford's Manning: bureaucracy has made universities worse for research — stanfordnlp · 2026-09-19
- Many 'misalignment' cases are really capability failures, argues researcher — xuanalogue · 2026-09-19